Treating Anemic Patients With Myelofibrosis in the New Janus Kinase Inhibitor Era: Current Evidence and Real-world Implications

• Aaron T. Gerds,
• Prithviraj Bose,
• Gabriela S. Hobbs,
• Andrew T. Kuykendall,
• Lynn M. Neilson,
• Jinlin Song,
• Barbara Klencke,
• Claire N. Harrison

Affiliations

Aaron T. Gerds

1 Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA

Prithviraj Bose

2 University of Texas, MD Anderson Cancer Center, Houston, TX, USA

Gabriela S. Hobbs

3 Massachusetts General Hospital, Boston, MA, USA

Andrew T. Kuykendall

4 Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA

Lynn M. Neilson

5 Sierra Oncology, Inc., San Mateo, CA, USA

Jinlin Song

6 Analysis Group Inc., Boston, MA, USA

Barbara Klencke

5 Sierra Oncology, Inc., San Mateo, CA, USA

Claire N. Harrison

7 Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom